


Univercells acquires SynHelix, entering into synthetic biology and the race to next-generation DNA synthesis

Advent France Biotechnology becomes AdBio partners

Integra Tx secures €4.5-million in funding from Advent France Biotechnology, Invivo Capital and Takeda Ventures
